ESTEEM研究PPT课件.pptVIP

 ESTEEM: Efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial infarction  Purpose To compare the efficacy and safety of four doses of oral ximelagatran with placebo in patients given acetylsalicylic acid with recent ST-elevation or non-ST-elevation myocardial infarction, and to investigate any dose-effect relation Reference Wallentin L, Wilcox RG, Weaver WD et al for the ESTEEM Investigators. Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial. Lancet 2003;362:789–97. ESTE